Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment

Journal article

SW Lewis, L Davies, PB Jones, TRE Barnes, RM Murray, R Kerwin, D Taylor, KP Hayhurst, A Markwick, H Lloyd, G Dunn

Health Technology Assessment | Published : 2006